Five Years of Cancer Drug Approvals: Innovation Efficacy and Costs (vol 1, pg 539, 2015)

被引：0

|

作者：

不详

机构：

来源：

JAMA ONCOLOGY | 2015年 / 1卷 / 04期

关键词：

D O I：

10.1001/jamaoncol.2015.1424

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：544 / 544

页数：1

相关论文

共 50 条

[1] Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs
Mailankody, Sham
Prasad, Vinay
JAMA ONCOLOGY, 2015, 1 (04) : 539 - 540
[2] The Evolution of a Cancer (vol 1, pg 698, 2015)
West, Howard
Jin, Jill O.
JAMA ONCOLOGY, 2015, 1 (06) : 850 - 850
[3] Breast cancer drug approvals by the US FDA from 1949 to 2018 (vol 19, pg 11, 2020)
Leo, P.
Leo, Cornelia
Szucs, Thomas D.
NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (04) : 291 - 291
[4] efficacy and safety of rufinamide in children under four years of age with drug-resistant epilepsies (vol 18, pg 641, 2015)
Grosso, Salvatore
Coppola, Giangennaro
Dontin, Serena Donetti
Gobbi, Giuseppe
Pruna, Dario
Accorsi, Patrizia
Verrotti, Alberto
Parisi, Pasquale
Balestri, Paolo
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2015, 19 (03) : 388 - 388
[5] Patterns of Cancer Costs in a Country With Detailed Individual Data (vol 53, pg 302, 2015)
Blakely, T.
Atkinson, J.
Kvizhinadze, G.
MEDICAL CARE, 2015, 53 (06) : 560 - 560
[6] Focus on Research: Structural Approaches to Cancer Drug Development (vol 373, pg 402, 2015)
Chabner, Bruce
Richon, Victoria
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (10): : 982 - 982
[7] Cancer drug developers counteract kinase gatekeeper mutations (vol 14, pg 667, 2015)
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (12) : 877 - 877
[8] Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour (vol 235, pg 539, 2015)
Chang, Yih-Leong
Liang, Cher-Wei
JOURNAL OF PATHOLOGY, 2015, 236 (01): : 131 - 131
[9] Efficacy and Safety of the Mosquitocidal Drug Ivermectin to Prevent Malaria Clinical Trial (vol 60, pg 357, 2015)
Ouedraogo, A. L.
Bastiaens, G. J. H.
Tiono, A. B.
CLINICAL INFECTIOUS DISEASES, 2016, 63 (05)
[10] Value of the 340B Drug Discount Program (vol 1, pg 1029, 2015)
Kantarjian, Hagop
Chapman, Robert
JAMA ONCOLOGY, 2015, 1 (08) : 1172 - 1172

← 1 2 3 4 5 →